BACAX | FANAX | BACAX / FANAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 28 years | - |
Gain YTD | 6.342 | 8.656 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 319M | 1.12B | 28% |
Annual Yield % from dividends | 2.76 | 1.79 | 154% |
Returns for 1 year | 15.73 | 18.30 | 86% |
Returns for 3 years | 40.64 | 57.63 | 71% |
Returns for 5 years | 63.47 | 95.06 | 67% |
Returns for 10 years | 37.93 | 60.28 | 63% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JBAFX | 29.41 | 0.20 | +0.68% |
JHancock Balanced R4 | |||
EMECX | 10.28 | 0.06 | +0.59% |
Ashmore Emerging Markets Equity C | |||
ACVUX | 8.45 | 0.04 | +0.48% |
American Century International Value I | |||
TBWCX | 17.60 | 0.01 | +0.06% |
Thornburg Better World International C | |||
LHCQX | 18.94 | -0.13 | -0.68% |
Lord Abbett Health Care R3 |